Exascale Labs Holdings Inc. XLAB TECH
Company Overview
Exascale Labs Holdings Inc. develops and operates AI computer infrastructure platforms. It offers graphics processing unit (GPU) cloud infrastructure, scalable GPU compute deployments, AI-ready data center solutions, system integration, GPU procurement and leasing, and full-stack orchestration. The company is based in Houston, Texas.
Why Investors Should Care
Generates a return on equity of 58.9%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 23.4%.
Revenue has grown at a 431.8% CAGR over the past five years.
Recent Developments
- Jun 2026 Revenue of $14.82M (+111.3% YoY); net profit $-12.16M.
- Trailing 12 Months Year-on-year growth — revenue +101.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 431.8%, profit CAGR -54.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 431.83% |
| 1 Year: | 101.60% |
Compounded Profit Growth
| 5 Years: | -54.54% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -66.16% |
| 6 Months: | -67.25% |
| 3 Months: | -57.00% |
| 1 Month: | +29.84% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)56.54 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 58.9%.
- Healthy ROCE of 23.4%.
- Compounding revenue at 431.8% over 5 years.
CONS
- Earnings shrank at -54.5% CAGR over 5 years.
- Trading 69.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLAB Exascale Labs Holdings Inc. TECH | 3.35 | -17.63 | $112.86M | 0.00% | 23.43% | 58.94% | 431.83% | -54.54% |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 210.96 | 26.64 | $5.09T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 347.72 | 39.88 | $5.07T | 0.32% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 524.51 | 29.19 | $3.89T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 418.51 | 31.19 | $2.17T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 321.68 | 41.08 | $1.54T | 0.72% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 877.55 | 19.82 | $991.10B | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 516.79 | 131.83 | $843.65B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,571.80 | 51.02 | $603.73B | 0.50% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 1.44M | 1.86M | 2.54M | 3.54M | 3.75M |
| Cost of Revenue | 1.19M | 1.65M | 2.08M | 3.02M | 3.17M |
| Gross Profit | 251.32K | 213.08K | 456.76K | 520.46K | 586.93K |
| Operating Expenses | 668.97K | 859.62K | 1.04M | 1.51M | 1.81M |
| Operating Income | -417.65K | -646.54K | -582.36K | -988.00K | -1.22M |
| EBITDA | -417.65K | -644.93K | -580.76K | -988.00K | -1.22M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | -1.60M | -1.54M | -1.48M | -3.77M | -2.63M |
| Tax Provision | 0 | 0 | 0 | 0 | 0 |
| Net Income | -1.60M | -1.54M | -1.48M | -3.77M | -2.63M |
| Diluted EPS | -0.03 | -0.02 | - | -0.06 | -0.04 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|
| Revenue | 1.32M | 7.02M | 14.82M |
| Cost of Revenue | 1.26M | 5.91M | - |
| Gross Profit | 55.57K | 1.11M | 2.42M |
| Operating Expenses | 1.90M | 4.15M | - |
| Operating Income | -1.85M | -3.04M | -4.80M |
| EBITDA | -1.84M | -3.04M | - |
| Interest Expense | - | - | - |
| Pretax Income | -4.96M | -7.66M | - |
| Tax Provision | 0 | 0 | - |
| Net Income | -4.96M | -7.66M | -12.16M |
| Diluted EPS | -0.08 | -0.12 | -8,108.26 |
| R&D Expense | - | 2.80M | 5.49M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|
| Total Assets | 4.39M | 7.32M | 6.73M |
| Current Assets | 4.37M | 7.30M | - |
| Cash & Equivalents | 969.63K | 4.23M | 2.69M |
| Inventory | - | - | - |
| Receivables | 123.33K | 152.54K | - |
| Total Liabilities | 9.88M | 20.32M | 31.89M |
| Current Liabilities | 9.88M | 20.32M | 31.89M |
| Long Term Debt | - | - | - |
| Total Debt | - | - | - |
| Total Equity | -5.49M | -13.00M | -25.16M |
| Shares Outstanding | 63.20M | 63.20M | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|
| Operating Cash Flow | -560.91K | -1.01M | -2.75M |
| Investing Cash Flow | -27.81K | -2.14K | 1.41M |
| Financing Cash Flow | 1.28M | 4.28M | -190.00K |
| Capital Expenditure | -27.81K | -2.14K | - |
| Free Cash Flow | -588.72K | -1.01M | - |
| Net Change in Cash | 696.28K | 3.26M | - |
Ratios (Annual)
Figures in %.
| Metric | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|
| Gross Margin % | 4.2% | 15.8% | 16.3% |
| Operating Margin % | -139.9% | -43.4% | -32.4% |
| Net Margin % | -375.7% | -109.2% | -82.1% |
| ROE % | 90.3% | 58.9% | 48.3% |
| ROCE % | 33.6% | 23.4% | 19.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for XLAB
Exascale Labs Holdings Inc. (XLAB) stock price, news, quote and history - Yahoo Finance Australia
<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTFBubVc2NzNMVG1GNDR1ZWNmWW10VEFMZWFjeC0yNEQxYm1PeERaWUptVFhOOU94bEpNb3Jxb0QyTEJXNXd3Z2ticVhkT3RSeHgyeGc?oc=5" target="_blank">Exascale Labs Holdings Inc. (XLAB) stock price, news, qu…
I Sold Too Early… And I’m GLAD I Did - Banyan Hill Publishing
<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5hLTQ1YnA4LU5jdURPWkRsNHhBTURtSHNiMkkyTWRQUENfV05vRjc3SXQ1QXBqSmxtY2x3Z1BwS0tfdkpUZXVzcFV3b3NkUnVjSms3QlhkVlBtTjZxU0ctSEtIOGRPM21wMGc?oc=5" target="_blank">I Sold Too Early… And I’…
Exascale Labs Holdings (XLAB) Stock Price, News & Analysis - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1WWjhqSVhmZEVzbGJacDE5RWlqbFJvTEpVNjlUWDNRR1BMLUJrLXp1QnpMbV9fdldoMHNUMlpja040a3k4MkVIa3VJbWczX3plU2o0?oc=5" target="_blank">Exascale Labs Holdings (XLAB) Stock Price, News & Analy…
Exascale Labs Holdings (Nasdaq:XLAB) - Stock Analysis - Simply Wall Street
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPMGtpTjMxVzU3VUx1TkhlbU56OHc3dW1mejA3Ylp6dHM3YUVFbkE2XzVldkpQZVlvV2hWZVlpNi1CeTlmMXlxWW5YTzFySTJWcVhWTkJOeURoWGdXN09fZmxiQ2gzMFNwTkUxWmdWeGo1X1ZqR2tYX2FVanV6X2JzTw?oc=5" target="_…
What is Market Cap of Exascale Labs Holdings Inc. - Ordinary Shares - Class A? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE5BVl81WjF1VVN2ckE3VHdwa01FczZhLUlSanVfUmp5dGt4M2lJVEtPNGo5U1NWeXd3U0haRDFPQlBGMW40UmxUTzlYdGlBenMtdEE?oc=5" target="_blank">What is Market Cap of Exascale Labs Holdings Inc. - Ordi…
$Exascale Labs (XLAB.US)$ - Moomoo
<a href="https://news.google.com/rss/articles/CBMi0gJBVV95cUxNamxOZHU2RTBWUlM1TlljenpFaGpGaTNWdm93QktmNHpiRW5PZ2RYWWZjV1JNUzQ1VzNhVktuODJTZnVFbDd3Y2QzRHNxa01RRk9rUFowM2wyMFpnN2V0M2EtdEl0c0RUdzRHZjBxN3NMbHE1OWNnQWJhVkZhWkhMdFBoeFhYNHNmWmV4U1…
XLAB — Frequently Asked Questions
What is the current share price of Exascale Labs Holdings Inc. (XLAB)?
As of 2026-10-23 16:27 PDT, Exascale Labs Holdings Inc. (XLAB) trades at $3.35 on NasdaqGM. Its 52-week range is $0.91 to $10.99.
What is the market capitalisation of XLAB?
Exascale Labs Holdings Inc. (XLAB) has a market capitalisation of $112.86M on NasdaqGM.
What is the P/E ratio of XLAB?
XLAB trades at a trailing price-to-earnings (P/E) ratio of -17.63. The industry average P/E is 30.29. Its price-to-book (P/B) ratio is -16.29.
What is the return on equity (ROE) of XLAB?
XLAB has a return on equity (ROE) of 58.94%. Its return on capital employed (ROCE) is 23.43%.
Is XLAB a good stock to buy?
This page provides a data-driven analysis of Exascale Labs Holdings Inc. (XLAB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.